Geniko Nosokomeio Peiraia Tzaneio

The Cardiology Clinic at Geniko Nosokomeio Peiraia Tzaneio is conducting research aimed at improving treatment of severe infections through more precise antibiotic use.

• Use of procalcitonin-guided therapy to tailor antibiotic duration
• Implementation of molecular diagnostics for rapid pathogen identification
• Strategies to reduce exposure to broad‑spectrum antibiotics

These efforts seek to lower resistance risk while maintaining patient safety.

Studies at the site focus on patients with atrial fibrillation to evaluate new anticoagulant options for preventing stroke and systemic embolism.

• Comparison of novel oral anticoagulant asundexian with standard therapy
• Assessment of major bleeding outcomes using international criteria
• Overall benefit‑risk profiling for stroke prevention

The goal is to identify safer and equally effective strategies for individuals at high cardiovascular risk.

The clinic is also exploring treatments for Atopic Dermatitis, testing a biologic agent combined with topical therapy.

• Evaluation of rocatinlimab added to corticosteroids or calcineurin inhibitors
• Measurement of disease severity using validated scores
• Placebo‑controlled assessment of symptom improvement

This research aims to enhance long‑term control of moderate‑to‑severe eczema.